EDISON PHARMACEUTICALS
Edison is a world leader in the discovery and development of redox drugs. The company has obtained orphan designation in both the United States and Europe for its first drug candidate, EPI-743 . Vincerinone is now in phase 2 clinical development. It is being evaluated in multiple clinical indications where defects in the mitochondrial proteins and redox control have been well characterized.
EDISON PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.edisonpharma.com
Total Employee:
11+
Status:
Active
Contact:
6504602070
Email Addresses:
[email protected]
Total Funding:
90.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx DigiCert SSL Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Encryption Everywhere
Similar Organizations
Actuate Therapeutics
Actuate Therapeutics provides advancing research to treatment of high impact cancers and neurodegenerative diseases.
ADMA Biologics
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alcyone Lifesciences
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
Alkahest
Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.
Antria
Antria is a clinical research firm developing regenerative medicine and cellular therapies for the treatment of diverse diseases.
Arbovax
Arbovax engages in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases.
Astute Medical
Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers.
AVM Biotechnology
AVM Biotechnology is a clinical stage company.
Axikin Pharmaceuticals
Axikin Pharmaceuticals develops small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases.
Biomeme
Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Weavr Health
Weavr Health is revolutionizing blood collection beyond the point of care including patients’ homes.
Boston Therapeutics
Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases.
Cannabics Pharmaceuticals
Cannabics Pharmaceuticals is dedicated to the development of Personalized Anti-Cancer treatments.
Cellix Bio
Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases.
EchoPixel
EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model.
Kiora Pharmaceuticals
Kiora Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Flame Biosciences
Flame Biosciences develops value-added medicines in the emerging area of inflammasome science.
Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Imago BioSciences
Imago is a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs).
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
IRX Therapeutics
IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases.
Klotho Therapeutics
Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Kolltan Pharmaceuticals
Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.
Liquid Grids
Liquid Grids empowers healthcare companies to listen, understand, and strategically engage in online health dialogues.
LTZ Therapeutics
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
MicuRx Pharmaceuticals
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Quadrant Biosciences
Quadrant Biosciences develop, test, and distribute products with expertise in engineering, production, marketing, and sales.
Napo Pharmaceuticals
Napo Pharmaceuticals develops and commercializes proprietary pharmaceuticals in collaboration with local partners.
Abliva AB
Abliva develops medicines for the treatment of primary mitochondrial diseases.
Nura Bio
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines.
Nuron Biotech
Nuron Biotech develops vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases.
Penn Medicine
Penn Medicine is the medical school of the University of Pennsylvania that provides medical research and education services.
Prospective Research
Prospective Research is creating feed incorporated preventative disease management solutions.
Retrotope
Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.
Senhwa Biosciences
Senhwa is a drug development company creating innovative therapies for cancer and related diseases.
Sky Medical Technology
Sky Medical develops bioelectronic medicine to prevent and treat acute and chronic circulatory conditions.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunbeam
Sunbeam Holdings, L.P. operates in the healthcare industry. Sunbeam Holdings, L.P. was incorporated in 2007 and is based in Sunrise,
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Trimel Pharmaceuticals
Trimel Pharmaceuticals develops medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
V-Wave
V Wave develops an implant for the treatment of congestive heart failure.
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Verax Biomedical
Verax Biomedical develops rapid tests for the detection of bacterial contaminants in cellular components for transfusion or transplant.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Employees Featured
Founder
Investors List
Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma investment in Venture Round - Edison Pharmaceuticals
Mitsui Global Investment
Mitsui Global Investment investment in Series F - Edison Pharmaceuticals
Paul Avery
Paul Avery investment in Series A - Edison Pharmaceuticals
